Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metaxin-3 is a mitochondrial membrane-associated protein encoded by the MTX3 gene in humans (HGNC: 24812; NCBI Gene: 345778)[2][5][6]. It is predicted to function in the import and organization of proteins within mitochondria, being part of the mitochondrial intermembrane space bridging (MIB) complex and associated with the sorting and assembly machinery (SAM) complex[2][6]. MTX3 is related to other metaxin family proteins (MTX1, MTX2) and is conserved across vertebrates[1][2]. While genetic studies note disease associations (including rare syndromes), Metaxin-3 is not currently a recognized therapeutic target for drugs or clinical interventions. Its principal role appears structural and organizational within mitochondrial biology, with no established functions in signal transduction, cell cycle, apoptosis, or other major pathways targeted in clinical pharmacology[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metaxin-3 (MTX3).